InsideArbitrage Potential Deal Alert: Magenta Therapeutics (MGTA) explores strategic alternatives
Magenta Therapeutics (MGTA), a clinical-stage biotechnology company focused on improving stem cell transplantation, announced that it has completed a review of its business, including the
Read More